Druggable genetic targets in endometrial cancer✰,✰✰
Background: FBXW7 is frequently somatically mutated in grade 3 endometrioid endometrial cancers (G3EECs) and serous endometrial cancers (SECs), high-risk cancers associated with poor prognosis. CRISPR-edited cell lines identified the proteomic and phosphoproteomic effects of FBXW7 mutation in 3 high...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2022-01-01
|
| Serie: | Cancer Treatment and Research Communications |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2468294221001982 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|